Preprint Mitochondrial Gene Signatures Illuminate Mitochondrial Function as an Important Contributor to Post-COVID Recovery and Long COVID Progression, 2024,..

Discussion in 'Long Covid research' started by pooriepoor91, Sep 12, 2024.

  1. pooriepoor91

    pooriepoor91 Established Member

    Messages:
    18
    https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4950019

    Authors: Ana R. Silverstein, Junxiang Wan, Kelvin Yen, Hemal H. Mehta, Hiroshi Kumagai, Melanie Flores, Jesse Goodrich, Howard Hu, Jeffrey D. Klausner, Omid Akbari, Igor Koralnik, Pinchas Cohen

    Abstract

    Long COVID, affecting an estimated 200 million individuals worldwide, is a poorly understood multisystem disorder following severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, with unclear causative factors. However, given common symptoms such as brain fog and chronic fatigue, we suggest that long COVID is partially regulated by changes to mitochondrial genes and energy homeostasis. We explore this here by assessing the differences in acute mitochondrial signatures between retrospectively diagnosed COVID convalescent and long COVID patients using two cohorts.

    For transcriptomic analyses, whole-blood RNA-seq results from publicly accessible data were extracted, assigned long-COVID or convalescent diagnosis retrospectively at 6-months post infection, and compared against non-symptomatic controls to assess for changes in mitochondrial specific gene signatures at 0-3 weeks post infection; revealing distinct mitochondrial gene expression patterns in those with and without long COVID manifestation.

    For proteomic analyses, plasma samples from 20 long COVID and 20 age- and sex matched COVID-convalescent participants were selected from the Southern California Clinical and Translational Science Institute COVID biorepository, and correlations between levels of 37 inflammatory biomarkers and three mitochondrial-derived peptides (MDPs) were assessed, revealing unique biomarker clustering between patients with and without long COVID.

    Combined, these findings suggest that successful COVID recovery is mediated in part by efficient mitochondrial repair and reduced oxidative stress, while mitochondrial dysfunction and continued dysregulation of mitochondrial gene expression contributes to chronic inflammation and long COVID onset.
     
    Last edited by a moderator: Sep 12, 2024
  2. Hutan

    Hutan Moderator Staff Member

    Messages:
    29,697
    Location:
    Aotearoa New Zealand
    University of Southern California
     
  3. Hutan

    Hutan Moderator Staff Member

    Messages:
    29,697
    Location:
    Aotearoa New Zealand
    METHOD
    A. Mitochondrial gene analysis
    Hospitalised - but this was in 2020 when maybe everyone who was positive may have been hospitalised



    B. Relationship between Mitochondrial derived peptides (MDPs) and inflammatory markers
    Samples taken 4 weeks after infection.
    20 Neurological-PASC (10 male, 10 female)
    20 Convalescent (less than 3 NeuroPASC symptoms)
    (I don't think number of symptoms is a very good measure. Fatigue is not a possible symptom, although malaise is.)

     
    Last edited: Sep 13, 2024
  4. Hutan

    Hutan Moderator Staff Member

    Messages:
    29,697
    Location:
    Aotearoa New Zealand
    RESULTS
    Part A
    I can't see how many of the 165 patients were labelled as having long COVID for the Part A analysis - can anyone find that?

    That's interesting, no sex bias in the development of long COVID, although perhaps the sample was too small and Long Covid is defined loosely.

    So, they looked at mitochondrial genes differentially expressed at 3 weeks after acute illness:
    Supplementary Table 2 lists expressed mitochondrial genes by group.
     
    Last edited: Sep 12, 2024
  5. Hutan

    Hutan Moderator Staff Member

    Messages:
    29,697
    Location:
    Aotearoa New Zealand
    RESULTS
    Part B
    Convalescent samples:
    NeuroPASC samples:
    I'm not sure that we should be too excited by these results. The sample size at 20 in each group is small. Not a single MDP or cytokine was significantly different between the two groups (see Table 2). So, they have turned to ratios between the biomarkers in order to find something. I'm not sure how stable the various cytokines are. And I'm not sure how good the classification of the people in the two groups is.


    But, if you look at Figure 3, the direction of correlations between many of the biomarkers does seem to be quite different in the two groups. So, perhaps that is evidence of a dysregulated system, perhaps, as is suggested in the introduction, a sign of immune systems being subverted by pathogens.
    a. Convalescent; b. NeuroPASC
    3 mitochondrial-derived peptides on the x axis; the 37 inflammatory markers on the y axis
    Screen Shot 2024-09-13 at 1.25.22 pm.png
     
    Last edited: Sep 13, 2024

Share This Page